04 Feb DePuy Synthes Announces Exclusive Expandable Cage Distribution Agreement with Expanding Innovations Inc.
The X-Pac Expandable Lumbar Cage System Meets Surgeons’ Evolving Needs Within Both the Lumbar Degenerative and Minimally Invasive Spine Segments
RAYNHAM, MA – FEBRUARY 2, 2021 – The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has signed an agreement with Expanding Innovations Inc. to distribute the X-Pac Expandable Lumbar Cage System in the U.S. The X-Pac Cage augments DePuy Synthes’ existing suite of products to provide a comprehensive procedural solution within the lumbar degenerative and minimally invasive spine segments.
Expanding Innovations Inc. has been dedicated to developing differentiated intellectual property and is deeply committed to revolutionizing expandable cages. The X-Pac Cage product portfolio is an example of the company’s commitment to offering innovative technology to spine surgeons.
“We are incredibly excited to collaborate with the Expanding Innovations team to bring the X-Pac Cage technology to U.S. spine surgeons,” said Russell Powers***, Worldwide President, DePuy Synthes Spine. “This next generation technology is well aligned with our robust portfolio and continued commitment to improve minimally invasive surgery, and we look forward to bringing this important innovation forward as a new option for patients.”
The X-Pac Expandable Lumbar Cage’s expansion mechanism provides controlled expansion of both height and lordosis to allow for intra-operative adjustment depending on the patient’s anatomy to meet their clinical needs. A differentiated lock ramp-feature built into the cage endplates leaves a large available graft space inside the cage for post graft packing. These benefits can enable surgeons to tailor treatment options for patients undergoing spinal fusion surgery.
“I have used many expandable cage options throughout my career and the X-Pac Cage presents certain advantages, including a unique design where the expansion mechanism is located in the inserter handle, enabling a low profile expansion ramp within the cage, which leaves space to abundantly and quickly backfill the cage with bone graft,” said Dr. Frank LaMarca****, Neurosurgeon, Jackson, Michigan. “The footprint and lordosis options allow me to choose the appropriate cage, while the dedicated positive locking mechanism gives me confidence that it will maintain height and lordosis until a solid fusion can be achieved. The EI X-Pac Cage has been an important addition to my spinal implant armamentarium.”
The X-Pac Cage technology is being showcased at the DePuy Synthes Minimally Invasive Spine Surgery Virtual Education Experience starting this week and concluding on February 10th. You can learn more about this event by clicking here.
About Johnson & Johnson Medical Devices Companies
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.
About DePuy Synthes
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.jnjmedicaldevices.com.
*Comprising the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment
**DePuy Synthes represents the products and services of DePuy Synthes Sales, Inc. and its affiliates.
*** Russell Powers is an employee of Medical Device Business Services, Inc.
****Dr. LaMarca is a paid consultant to DePuy Synthes
The third-party trademarks used herein are trademarks of their respective owners. Please refer to the instructions for use for a complete list of indications, contraindications, warnings and precautions.
165505-210126 DSUS
SOURCE: DePuy, 2nd February 2021